Search Articles — Sudonull

Search Results

In this project

T-Technologies: Open Source Strategy in AI/ML and LLM Development

https://sudonull.com/t-technologies-open-source-strategy-in-ai-ml-and-llm-development

How the T-Technologies Group develops open source ecosystems in AI/ML, creating LLMs (T-Pro 2.0, T-One) and tools (Turbo Alignment), as well as investing in research and the community.

Why developers don't trust AI content and code

https://sudonull.com/why-developers-don-t-trust-ai-content-and-code

Study of the reasons for rejection of AI-generated content and code among IT specialists: psychology, information theory, and practical detection markers.

AI Won't Replace IT Specialists: 9 Facts

https://sudonull.com/ai-won-t-replace-it-specialists-9-facts

Learn why AI won't take jobs from developers: failed forecasts, low ROI, model errors. Facts and data for middle/senior IT. Adapt skills to reality.

Code Economy: Rust Doesn't Pay Off in Projects

https://sudonull.com/code-economy-rust-doesn-t-pay-off-in-projects

Breakdown of why switching to memory-safe languages doesn't reduce development costs. Software Economic Model: TCO, bug fixes, payback. For middle/senior dev. Read the analysis.

From other projects

T-Beauty in Taiwan: AI Skin Diagnostics and Expansion

https://ymaho.com/t-beauty-in-taiwan-ai-skin-diagnostics-and-expansion

Thailand brings T-Beauty to Taiwan through AI skin analysis and cellular restoration. Learn how data strategy is changing the Asian market. Read the analysis.

Dual-action CAR-T: 100% remission in myeloma at ISCT 2026

https://ymaho.com/dual-action-car-t-100-remission-in-myeloma-at-isct-2026

ISCT 2026 data analysis: CAR-T therapy TPST-2003 showed complete response in all naive patients. Learn why this is a breakthrough, not an illusion, and what risks are hidden.

CAR-T therapy HIV: years of remission after infusion

https://ymaho.com/car-t-therapy-hiv-years-of-remission-after-infusion

DUET-2 data: CAR-T cells keep HIV in remission for over 2 years without ART. Functional cure already a reality? Learn about the breakthrough in HIV treatment.

CAR-T therapy for lupus: FDA approval 2026

https://ymaho.com/car-t-therapy-for-lupus-fda-approval-2026

Analysis of FDA approval of the first CAR-T cell therapy for severe lupus. Key players, forecasts, and hidden risks. Find out who is leading the race.

CAR-T therapy against aging: elimination of senescent cells

https://ymaho.com/car-t-therapy-against-aging-elimination-of-senescent-cells

An international consortium has developed CAR-T for selective elimination of senescent cells. Learn how uPAR CAR-T technology fights age-related diseases and fibrosis.

From the web

TikTok - Make Your Day

https://t.tiktok.com/

TikTok - trends start here. On a device or on the web, viewers can watch and discover millions of personalized short videos. Download the app to get started.

20 hours ago ·

https://www.marketwatch.com/investing/stock/t

20 hours ago · View real-time stock prices and stock quotes for a full financial overview.

Searches related to T.js

https://www.cnn.com/markets/stocks/T

View AT&T Inc T stock quote prices, financial information, real-time forecasts, and company news from CNN.

Trending Now